Pacer Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$344K Buy
+1,425
New +$344K ﹤0.01% 1525
2025
Q1
Sell
-2,782
Closed -$914K 3627
2024
Q4
$914K Sell
2,782
-30
-1% -$9.86K ﹤0.01% 1389
2024
Q3
$941K Buy
2,812
+233
+9% +$78K ﹤0.01% 1401
2024
Q2
$704K Buy
2,579
+1,124
+77% +$307K ﹤0.01% 1454
2024
Q1
$503K Buy
1,455
+38
+3% +$13.1K ﹤0.01% 1545
2023
Q4
$458K Sell
1,417
-2,925
-67% -$944K ﹤0.01% 1554
2023
Q3
$1.56M Buy
4,342
+624
+17% +$224K 0.01% 664
2023
Q2
$1.41M Buy
3,718
+1,766
+90% +$670K 0.01% 884
2023
Q1
$935K Buy
1,952
+1,595
+447% +$764K ﹤0.01% 963
2022
Q4
$150K Sell
357
-1,042
-74% -$438K ﹤0.01% 2411
2022
Q3
$584K Buy
1,399
+90
+7% +$37.6K ﹤0.01% 697
2022
Q2
$648K Sell
1,309
-780
-37% -$386K ﹤0.01% 630
2022
Q1
$1.18M Buy
2,089
+931
+80% +$525K 0.01% 834
2021
Q4
$875K Sell
1,158
-834
-42% -$630K 0.01% 1293
2021
Q3
$1.49M Sell
1,992
-309
-13% -$231K 0.02% 740
2021
Q2
$1.48M Buy
2,301
+1,085
+89% +$699K 0.02% 699
2021
Q1
$695K Sell
1,216
-195
-14% -$111K 0.01% 914
2020
Q4
$823K Sell
1,411
-1,106
-44% -$645K 0.02% 782
2020
Q3
$1.3M Sell
2,517
-388
-13% -$200K 0.03% 597
2020
Q2
$1.31M Buy
2,905
+2,873
+8,978% +$1.3M 0.03% 487
2020
Q1
$14K Sell
32
-7,309
-100% -$3.2M ﹤0.01% 590
2019
Q4
$2.72M Sell
7,341
-427
-5% -$158K 0.12% 175
2019
Q3
$2.59M Sell
7,768
-284
-4% -$94.5K 0.06% 379
2019
Q2
$2.52M Buy
8,052
+8,012
+20,030% +$2.5M 0.06% 365
2019
Q1
$12K Sell
40
-47
-54% -$14.1K ﹤0.01% 718
2018
Q4
$20K Sell
87
-7,165
-99% -$1.65M ﹤0.01% 386
2018
Q3
$2.27M Buy
7,252
+848
+13% +$265K 0.09% 285
2018
Q2
$1.85M Buy
6,404
+871
+16% +$251K 0.08% 304
2018
Q1
$1.38M Buy
5,533
+666
+14% +$167K 0.08% 332
2017
Q4
$1.16M Buy
4,867
+1,096
+29% +$262K 0.08% 349
2017
Q3
$838K Buy
3,771
+465
+14% +$103K 0.07% 382
2017
Q2
$748K Buy
3,306
+471
+17% +$107K 0.07% 382
2017
Q1
$565K Buy
2,835
+687
+32% +$137K 0.07% 426
2016
Q4
$392K Buy
2,148
+207
+11% +$37.8K 0.06% 533
2016
Q3
$318K Buy
1,941
+168
+9% +$27.5K 0.05% 573
2016
Q2
$254K Buy
+1,773
New +$254K 0.04% 672